Optimum radiation dose for palliation in head and neck squamous cell carcinoma (OpRAH) - A phase 3 randomized controlled trial.
Mallick S, Dagar A, Ghosh A, Aashita, Raj J, Hazarika S, Meena JK, Kumar A, Sharma J, Panda S, Sharma A, Singh M, Sharma D, Thakar A.
Mallick S, et al. Among authors: dagar a.
Radiother Oncol. 2025 Jan;202:110611. doi: 10.1016/j.radonc.2024.110611. Epub 2024 Nov 8.
Radiother Oncol. 2025.
PMID: 39522825
Clinical Trial.